Early alterations in cytokine expression in adult compared to developing lung in mice after radiation exposure

Radiation Research

Volumn 173, Issue 4, 2010, Pages 522-535

  Johnston, Carl J ^a   Hernady, Eric ^a   Reed, Christina ^a   Thurston, Sally W ^a   Finkelstein, Jacob N ^a   Williams, Jacqueline P ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CCR1; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CXCR2; CHEMOKINE RECEPTOR CXCR3; CXCL1 CHEMOKINE; CYTOKINE; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 1 RECEPTOR TYPE II; INTERLEUKIN 12P40; INTERLEUKIN 12P70; INTERLEUKIN 13; INTERLEUKIN 17; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 3; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; INTERLEUKIN 9; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; PLASMA PROTEIN; RANTES; TUMOR NECROSIS FACTOR ALPHA; UNINDEXED DRUG; VASCULOTROPIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DOSIMETRY; FEMALE; GENE EXPRESSION; LUNG DEVELOPMENT; LUNG INJURY; LUNG PARENCHYMA; MOUSE; NONHUMAN; POSTNATAL DEVELOPMENT; PRIORITY JOURNAL; PROTEIN EXPRESSION; RADIATION EXPOSURE; TERRORISM; TISSUE REACTION; WHOLE BODY RADIATION;

AGING; ANIMALS; CYTOKINES; DOSE-RESPONSE RELATIONSHIP, RADIATION; FEMALE; GENE EXPRESSION REGULATION, DEVELOPMENTAL; LUNG; MALE; MICE; MICE, INBRED C57BL; RADIATION DOSAGE; WHOLE-BODY IRRADIATION;

MUS;

EID: 77950266006     PISSN: 00337587     EISSN: None     Source Type: Journal    
DOI: 10.1667/RR1882.1     Document Type: Article

References (52)

1. A. J. Gonzalez, Lauriston S. Taylor Lecture: Radiation protection in the aftermath of a terrorist attack involving exposure to ionizing radiation. Health Phys. 89, 418-446 (2005).
2. NIH Strategic Plan and Research Agenda for Medical Countermeasures Against Radiological and Nuclear Threats. NIH Publication No. 05-5608, U.S. Department of Health and Human Services, Washington, DC, 2005
3. Continuation of national emergency regarding the proliferation of weapons of mass destruction. Fed. Regist. 71, 64109 (2006).
4. UNSCEAR, Sources, Effects and Risks of Ionizing Radiation. Report to the General Assembly, Annex J: Exposures and Effects of the Chernobyl Accident. United Nations, New York, 2000.
5. T. Hirama, S. Tanosaki, S. Kandatsu, N. Kuroiwa, T. Kamada, H. Tsuji, S. Yamada, H. Katoh, N. Yamamoto and M. Akashi, Initial medical management of patients severely irradiated in the Tokai-mura criticality accident. Br. J. Radiol. 76, 246-253 (2003).
6. B. Bennett, M. Repacholi and Z. Carr, Health Effects of the Chernobyl Accident and Special Health Care Programmes. World Health Organization, Geneva, 2006.
7. T. Hirama and M. Akashi, Multi-organ involvement in the patient who survived the Tokai-mura criticality accident. Br. J. Radiol. Suppl. 27, 17-20 (2005).
8. H. B. Stone, W. H. McBride and C. N. Coleman, Modifying normal tissue damage postirradiation. Report of a workshop sponsored by the Radiation Research Program, National Cancer Institute, Bethesda, Maryland, September 6-8, 2000. Radiat. Res. 157, 204-223 (2002).
9. J. P. Williams, E. Hernady, C. J. Johnston, C. M. Reed, B. Fenton, P. Okunieff and J. N. Finkelstein, Effect of administration of lovastatin on the development of late pulmonary effects after whole-lung irradiation in a murine model. Radiat. Res. 161, 560-567 (2004).
10. A. Molteni, L. F. Wolfe, W. F. Ward, C. H. Ts'ao, L. B. Molteni, P. Veno, B. L. Fish, J. M. Taylor, N. Quintanilla and J. E. Moulder, Effect of an angiotensin II receptor blocker and two angiotensin converting enzyme inhibitors on transforming growth factor-beta (TGF-beta) and alpha-actomyosin (alpha SMA), important mediators of radiation-induced pneumopathy and lung fibrosis. Curr. Pharm. Des. 13, 1307-1316 (2007).
11. E. L. Travis, R. A. Harley, J. O. Fenn, C. J. Klobukowski and H. B. Hargrove, Pathologic changes in the lung following single and multi-fraction irradiation. Int. J. Radiat. Oncol. Biol. Phys. 2, 475-490 (1977).
12. E. L. Travis, The sequence of histological changes in mouse lungs after single doses of X-rays. Int. J. Radiat. Oncol. Biol. Phys. 6, 345-347 (1980).
13. J. Sharplin and A. J. Franko, A quantitative histological study of strain-dependent differences in the effects of irradiation on mouse lung during the early phase. Radiat. Res. 119, 1-14 (1989).
14. J. Sharplin and A. J. Franko, A quantitative histological study of strain-dependent differences in the effects of irradiation on mouse lung during the intermediate and late phases. Radiat. Res. 119, 15-31 (1989).
15. E. S. Yi, A. Bedoya, H. Lee, E. Chin, W. Saunders, S. J. Kim, D. Danielpour, D. G. Remick, S. Yin and T. R. Ulich, Radiation-induced lung injury in vivo: expression of transforming growth factor-beta precedes fibrosis. Inflammation 20, 339-352 (1996).
16. A. J. Franko and J. Sharplin, Development of fibrosis after lung irradiation in relation to inflammation and lung function in a mouse strain prone to fibrosis. Radiat. Res. 140, 347-355 (1994).
17. A. J. Franko, J. Sharplin, A. Ghahary and M. H. Barcellos-Hoff, Immunohistochemical localization of transforming growth factor beta and tumor necrosis factor alpha in the lungs of fibrosis-prone and "non- fibrosing" mice during the latent period and early phase after irradiation. Radiat. Res. 147, 245-256 (1997).
18. P. Rubin, C. J. Johnston, J. P. Williams, S. McDonald and J. N. Finkelstein, A perpetual cascade of cytokines post-irradiation leads to pulmonary fibrosis. Int. J. Radiat. Oncol. Biol. Phys. 33, 99-109 (1995).
19. C. J. Johnston, B. Piedboeuf, P. Rubin, J. P. Williams, R. Baggs and J. N. Finkelstein, Early and persistent alterations in the expression of interleukin-1 alpha, interleukin-1 beta and tumor necrosis factor alpha mRNA levels in fibrosis-resistant and sensitive mice after thoracic irradiation. Radiat. Res. 145, 762-767 (1996).
20. B. Juste, N. Villaescusa, D. Granero and G. Verdu, Improving pediatric radiation dose management using Agfa digital radiography DICOM header information. Conf. Proc. IEEE Eng. Med. Biol. Soc. 4457-4459 (2007).
21. P. Vock, CT radiation exposure in children: Consequences of the American discussion for Europe. Radiologe 42, 697-702 (2002).
22. D. L. Friedman and L. S. Constine, Late effects of cancer treatment. In Pediatric Radiation Oncology, 4th ed. (E. C. Halperin, L. S. Constine, N. J. Tarbell and and L. E. Kun, Eds.), pp. 523-612. Lippincott Williams & Wilkins, Philadelphia, 2005.
23. P. H. Burri, Postnatal development and growth. In The Lung: Scientific Foundations, Vol.1 (R. G. Crystal, J. B. West, E. R. Weibel and and P. J. Barnes, Eds.), pp. 1013-1026. Lippincott-Raven, Philadelphia, 1997.
24. P. H. Burri, Structural aspects of postnatal lung development\ alveolar formation and growth. Biol. Neonate 89, 313-322 (2006).
25. W. Shi, S. Bellusci and D. Warburton, Lung development and adult lung diseases. Chest 132, 651-656 (2007).
26. M. J. Kresch, C. Christian, F. Wu and N. Hussain, Ontogeny of apoptosis during lung development. Pediatr. Res. 43, 426-431 (1998).
27. C. Luyet, P. H. Burri and J. C. Schittny, Pre-and postnatal lung development, maturation, and plasticity. Suppression of cell proliferation and programmed cell death by dexamethasone during postnatal lung development. Am. J. Physiol. Lung Cell Mol. Physiol. 282, L477-L483 (2002).
28. C. N. Coleman, C. Hrdina, J. L. Bader, A. Norwood, R. Hayhurst, J. Forsha, K. Yeskey and A. Knebel, Medical response to a radiological/nuclear event: Integrated plan from the Office of the Assistant Secretary for Preparedness and Response, Department of Health and Human Services. Ann. Emerg. Med. 53, 213-222 (2009).
29. D. L. Preston, Y. Shimizu, D.A. Pierce, A. Suyama and K. Mabuchi, Studies of mortality of atomic bomb survivors. Report 13: Solid cancer and noncancer disease mortality: 1950-1997. Radiat. Res. 160, 381-407 (2008).
30. P. Rubin, J. Finkelstein and D. Shapiro, Molecular biology mechanisms in the radiation induction of pulmonary injury syndromes: interrelationship between the alveolar macrophage and the septal fibroblast. Int. J. Radiat. Oncol. Biol. Phys. 24, 93-101 (1992).
31. S. Paul and S. A. Amundson, Development of gene expression signatures for practical radiation biodosimetry. Int. J. Radiat. Oncol. Biol. Phys. 71, 1236-1244 (2008).
32. J. M. Daun and M. J. Fenton, Interleukin-1/Toll receptor family members: receptor structure and signal transduction pathways. J. Interferon Cyt. Res. 20, 843-855 (2000).
33. A. Mantovani, R. Bonecchi, F. O. Martinez, E. Galliera, P. Perrier, P. Allavena and M. Locati, Tuning of innate immunity and polarized responses by decoy receptors. Int. Arch. Allergy Immunol. 132, 109-115 (2003).
34. F. Docagne, S. J. Campbell, A. F. Bristow, S. Poole, S. Vigues, C. Guaza, V. H. Perry and D. C. Anthony, Differential regulation of type I and type II interleukin-1 receptors in focal brain inflammation. Eur. J. Neurosci. 21, 1205-1214 (2005).
35. C. Bellehumeur, T. Collette, R. Maheux, J. Mailloux, M. Villeneuve and A. Akoum, Increased soluble interleukin-1 receptor type II proteolysis in the endometrium of women with endometriosis. Hum. Reprod. 20, 1177-1184 (2005).
36. E. Garcia-Ramallo, T. Marques, N. Prats, J. Beleta, S. Kunkel and N. Godessart, Resident cell chemokine expression serves as the major mechanism for leukocyte recruitment during local inflammation. J. Immunol. 169, 6467-6473 (2002).
37. J. A. Belperio, M. P. Keane, M. D. Burdick, B. N. Gomperts, Y. Y. Xue, K. Hong, J. Mestas, D. Zisman, A. Ardehali and R. M. Strieter, CXCR2/CXCR2 ligand biology during lung transplant ischemia-reperfusion injury. J. Immunol. 175, 6931-6939 (2005).
38. M. D. Wareing, A. L. Shea, C. A. Inglis, P. B. Dias and S. R. Sarawar, CXCR2 is required for neutrophil recruitment to the lung during influenza virus infection, but is not essential for viral clearance. Viral Immunol. 20, 369-378 (2007).
39. V. Nomellini, D. E. Faunce, C. R. Gomez and E. J. Kovacs, An age-associated increase in pulmonary inflammation after burn injury is abrogated by CXCR2 inhibition. J. Leuk. Biol. 83, 1493-1501 (2008).
40. Y. Chen, J. Williams, I. Ding, E. Hernady, W. Liu, T. Smudzin, J. N. Finkelstein, P. Rubin and P. Okunieff, Radiation pneumonitis and early circulatory cytokine markers. Semin. Radiat. Oncol. 12 (Suppl. 1), 26-33 (2002).
41. Y. Chen, O. Hyrien, J. Williams, P. Okunieff, T. Smudzin and P. Rubin, Interleukin (IL)-1A and IL-6: applications to the predictive diagnostic testing of radiation pneumonitis. Int. J. Radiat. Oncol. Biol. Phys. 62, 260-266 (2005).
42. F. Kong, R. L. Jirtle, D. H. Huang, R. W. Clough and M. S. Anscher, Plasma transforming growth factor-beta1 level before radiotherapy correlates with long term outcome of patients with lung carcinoma. Cancer 86, 1712-1719 (1999).
43. M. S. Anscher, L. B. Marks, T. D. Shafman, R. Clough, H. Huang, A. Tisch, M. Munley, J. E. Herndon, II, J. Garst and R. L. Jirtle, Using plasma transforming growth factor beta-1 during radiotherapy to select patients for dose escalation. J. Clin. Oncol. 19, 3758-3765 (2001).
44. R. C. Russo, R. Guabiraba, C. C. Garcia, L. S. Barcelos, E. Roffe, A. L. Souza, F. A. Amaral, D. Cisalpino, G. D. Cassali and M. M. Teixeira, Role of the chemokine receptor CXCR2 in bleomycin-induced pulmonary inflammation and fibrosis. Am. J. Respir. Cell Mol. Biol. 40, 410-421 (2009).
45. A. Fucic, G. Brunborg, R. Lasan, D. Jezek, L. E. Knudsen and D. F. Merlo, Genomic damage in children accidentally exposed to ionizing radiation: a review of the literature. Mutat. Res. 658, 111-123 (2008).
46. I. Kolpakov, Nerespiratorni funktsii leheniv u ditei, iaki zaznaly khronichnoho vplyvu ionizuiuchoho vyprominiuvannia v rezul'tati avarii na ChAES. Likarska Sprava 23-26 (1999).
47. J. Heinrich and R. Slama, Fine particles, a major threat to children. Int. J. Hygiene Environ. Health 210, 617-622 (2007).
48. J. Henderson, A. Sherriff, A. Farrow and J. G. Ayres, Household chemicals, persistent wheezing and lung function: effect modification by atopy? Eur. Respir. J. 31, 547-554 (2008).
49. K. N. Priftis, E. C. Mantzouranis and M. B. Anthracopoulos, Asthma symptoms and airway narrowing in children growing up in an urban versus rural environment. J. Asthma 46, 244-251 (2009).
50. R. Kajekar, Environmental factors and developmental outcomes in the lung. Pharmacol. Ther. 114, 129-145 (2007).
51. C. J. Johnston, B. A. Holm and J. N. Finkelstein, Sequential exposures to ozone and lipopolysaccharide in postnatal lung enhance or inhibit cytokine responses. Exp. Lung Res. 31, 431-447 (2005).
52. 137Cs. Health Phys. 73, 320-332 (1997).